SCHEMBL4133440

SCHEMBL4133440

COc1ccc2cc(C=C3SC(Nc4ccc(CCC(=O)O)cc4)=NC3=O)ccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 10/20 0.54
FFAR1 O14842 2/20 0.44
HDAC4 P56524 2/20 0.44
HDAC8 Q9BY41 1/20 0.42
KDM1A O60341 1/20 0.41
MAPT P10636 3/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 1/20 0.41
MITF O75030 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4133434 1.00 ALOX5 (0.54) ALOX5FFAR1HDAC4HDAC8KDM1A
SCHEMBL4133593 0.91 ALOX5 (0.50) ALOX5HDAC4HDAC8MAPTRAB9A
SCHEMBL4133591 0.91 ALOX5 (0.50) ALOX5HDAC4HDAC8MAPTRAB9A
SCHEMBL4635037 0.89 FFAR1 (0.49) ALOX5FFAR1HDAC4HDAC8RAB9A
SCHEMBL4635040 0.89 FFAR1 (0.49) ALOX5FFAR1HDAC4HDAC8RAB9A
SCHEMBL4128880 0.87 HDAC4 (0.44) ALOX5HDAC4HDAC8MAPTRAB9A
SCHEMBL4128877 0.87 HDAC4 (0.44) ALOX5HDAC4HDAC8MAPTRAB9A
Acetic Acid SCHEMBL4134639 0.84 ALOX5 (0.51) ALOX5HDAC4HDAC8MAPTRAB9A
Acetic Acid SCHEMBL4134637 0.84 ALOX5 (0.51) ALOX5HDAC4HDAC8MAPTRAB9A
SCHEMBL4122948 0.81 ALOX5 (0.48) ALOX5HDAC4HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US claimed
EP-1934192-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS Torrent Pharmaceuticals Ltd (IN) 2008-06-25 EP claimed
WO-2007032028-A1 THIAZOLINONES AND OXAZOLINONES AND THEIR USE AS PTP1B INHIBITORS TORRENT PHARMACEUTICALS LTD. (IN) 2007-03-22 WO claimed
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors TORRENT PHARMACEUTICALS LIMITED (IN) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088432-A1 Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors PTPRF, PTPA, PTPRJ ALOX5 3505/4885FFAR1 1878/4885HDAC4 2224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.